Meet us at InformEx USA (7-10 February 2011): Booths 20878 February 2011
BUBENDORF, Switzerland (February 8, 2011) — Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (
The company is presenting its integrated contract services spanning from process research and development of active pharmaceutical ingredients (APIs) and Highly Potent APIs (HPAPIs) to large-scale manufacturing and life cycle management. CARBOGEN AMCIS recently announced the installation of new stability chambers at its Hunzenschwil (Neuland), Switzerland site to support short-term, long-term, accelerated, intermediate, follow-up and customized tests for active ingredients and new chemical entities (NCEs) at any stage of development.
During the InformEx educational conference program, Maarten Prause, CARBOGEN AMCIS’ industrial hygienist, is giving an educational presentation entitled: “Embracing Risk-mapp Guidelines” on Thursday, February 10th from 8-8:45am in the General Chemistry Conference Sessions.
CARBOGEN AMCIS AG is a leading service provider, offering a portfolio of drug-development and commercialization services to the pharmaceutical and biopharmaceutical industry at all stages of drug development. The integrated services provide innovative chemistry solutions to support timely and safe drug development allowing customers to make the best use of available resources. CARBOGEN AMCIS AG is owned by Dishman Pharmaceuticals and Chemicals Ltd., Ahmedabad, India.